Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study.
Panhaleux M, Espitia O, Terrier B, Manson G, Maria A, Humbert S, Godbert B, Perrin J, Achille A, Arrondeau J, Kostine M, Fallet V, Pugnet G, Chaigne B, Champiat S, Laparra A, Danlos FX, Launay D, Penel N, Lambotte O, Michot JM, Forestier A. Panhaleux M, et al. Among authors: espitia o. Eur J Cancer. 2022 Jan;160:134-139. doi: 10.1016/j.ejca.2021.10.018. Epub 2021 Nov 19. Eur J Cancer. 2022. PMID: 34810048 Clinical Trial.
Risk for recurrence of symptomatic upper-extremity deep vein thrombosis in patients without cancer: Analysis of three RIETE cohorts.
Núñez Fernández MJ, Padín Paz EM, Vázquez Temprano N, Nieto Rodríguez JA, Marchena Yglesias PJ, Imbalzano E, Montenegro AC, Fernández Jiménez B, Rivera A, Espitia O, Monreal M. Núñez Fernández MJ, et al. Among authors: espitia o. Vasc Med. 2023 Aug;28(4):324-330. doi: 10.1177/1358863X231175185. Epub 2023 Jun 5. Vasc Med. 2023. PMID: 37272085
[Three cases of Jaccoud's arthropathy during systemic sclerosis].
Najm A, Le Goff B, Achille A, Espitia O, Durant C, Perrin F, Agard C. Najm A, et al. Among authors: espitia o. Rev Med Interne. 2016 Oct;37(10):708-713. doi: 10.1016/j.revmed.2016.01.007. Epub 2016 Feb 8. Rev Med Interne. 2016. PMID: 26869295 French.
Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study.
Moulis G, Pugnet G, Costedoat-Chalumeau N, Mathian A, Leroux G, Boutémy J, Espitia O, Bouillet L, Berthier S, Gaultier JB, Jeandel PY, Konaté A, Mékinian A, Solau-Gervais E, Terrier B, Wendling D, Andry F, Garnier C, Cathébras P, Arnaud L, Palmaro A, Cacoub P, Amoura Z, Piette JC, Arlet P, Lapeyre-Mestre M, Sailler L. Moulis G, et al. Among authors: espitia o. Ann Rheum Dis. 2018 Aug;77(8):1172-1178. doi: 10.1136/annrheumdis-2017-212705. Epub 2018 Mar 13. Ann Rheum Dis. 2018. PMID: 29535124
Large-vessel vasculitis diagnosed between 50 and 60 years: Case-control study based on 183 cases and 183 controls aged over 60 years.
Delaval L, Daumas A, Samson M, Ebbo M, De Boysson H, Liozon E, Dupuy H, Puyade M, Blockmans D, Benhamou Y, Sacré K, Berezne A, Devilliers H, Pugnet G, Maurier F, Zénone T, de Moreuil C, Lifermann F, Arnaud L, Espitia O, Deroux A, Grobost V, Lazaro E, Agard C, Balageas A, Bouiller K, Durel CA, Humbert S, Rieu V, Roriz M, Souchaud-Debouverie O, Vinzio S, Nguyen Y, Régent A, Guillevin L, Terrier B. Delaval L, et al. Among authors: espitia o. Autoimmun Rev. 2019 Jul;18(7):714-720. doi: 10.1016/j.autrev.2019.05.008. Epub 2019 May 4. Autoimmun Rev. 2019. PMID: 31059846
Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis.
de Boysson H, Le Besnerais M, Blaison F, Daumas A, Jarrot PA, Perrin F, Tieulié N, Maria A, Duffau P, Gombert B, Samson M, Espitia O, Lambert M, Mékinian A, Aouba A; French Study Group for Large Vessel Vasculitis (GEFA). de Boysson H, et al. Among authors: espitia o. Arthritis Res Ther. 2021 May 19;23(1):143. doi: 10.1186/s13075-021-02529-4. Arthritis Res Ther. 2021. PMID: 34011407 Free PMC article.
Large-vessel involvement is predictive of multiple relapses in giant cell arteritis.
de Mornac D, Espitia O, Néel A, Connault J, Masseau A, Espitia-Thibault A, Artifoni M, Achille A, Wahbi A, Lacou M, Durant C, Pottier P, Perrin F, Graveleau J, Hamidou M, Hardouin JB, Agard C. de Mornac D, et al. Among authors: espitia o, espitia thibault a. Ther Adv Musculoskelet Dis. 2021 May 18;13:1759720X211009029. doi: 10.1177/1759720X211009029. eCollection 2021. Ther Adv Musculoskelet Dis. 2021. PMID: 34046092 Free PMC article.
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients.
Mekinian A, Biard L, Dagna L, Novikov P, Salvarani C, Espitia O, Sciascia S, Michaud M, Lambert M, Hernández-Rodríguez J, Schleinitz N, Awisat A, Puéchal X, Aouba A, Munoz Pons H, Smitienko I, Gaultier JB, Le Mouel E, Benhamou Y, Perlat A, Jego P, Goulenok T, Sacre K, Lioger B, Hassold N, Broner J, Dufrost V, Sene T, Seguier J, Maurier F, Berthier S, Belot A, Frikha F, Denis G, Audemard-Verger A, Kone Pault I, Humbert S, Woaye-Hune P, Tomelleri A, Baldissera E, Kuwana M, Lo Gullo A, Gaches F, Zeminsky P, Galli E, Alvarado M, Boiardi L, Muratore F, Vautier M, Campochiaro C, Moiseev S, Cacoub P, Fain O, Saadoun D; French Takayasu network. Mekinian A, et al. Among authors: espitia o. Rheumatology (Oxford). 2022 Apr 11;61(4):1376-1384. doi: 10.1093/rheumatology/keab635. Rheumatology (Oxford). 2022. PMID: 34363461
122 results